Pseudomonas aeruginosa alginate promotes Burkholderia cenocepacia persistence in cystic fibrosis transmembrane conductance regulator knockout mice

Infection and Immunity

Volumn 78, Issue 3, 2010, Pages 984-993

  Chattoraj, Sangbrita S ^a   Murthy, Rachana ^a   Ganesan, Shyamala ^a   Goldberg, Joanna B ^c   Zhao, Ying ^a   Hershenson, Marc B ^a,b   Sajjan, Umadevi S ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALGINIC ACID; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BURKHOLDERIA CENOCEPACIA; HISTOPATHOLOGY; LUNG FIBROSIS; MOUSE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

ALGINATES; ANIMALS; BURKHOLDERIA; BURKHOLDERIA INFECTIONS; COLONY COUNT, MICROBIAL; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; CYTOKINES; GLUCURONIC ACID; HEXURONIC ACIDS; HISTOCYTOCHEMISTRY; LUNG; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROSCOPY; PSEUDOMONAS AERUGINOSA;

EID: 77349113999     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01192-09     Document Type: Article

References (45)

1. Cabral, D. A., B. A. Loh, and D. P. Speert. 1987. Mucoid Pseudomonas aeruginosa resists nonopsonic phagocytosis by human neutrophils and macrophages. Pediatr. Res. 22:429-431.
2. Cesaretti, M., E. Luppi, F. Maccari, and N. Volpi. 2003. A 96-well assay for uronic acid carbazole reaction. Carbohydr. Polym. 54:59-61.
3. Cieri, M. V., N. Mayer-Hamblett, A. Griffith, and J. L. Burns. 2002. Correlation between an in vitro invasion assay and a murine model of Burkholderia cepacia lung infection. Infect. Immun. 70:1081-1086.
4. Gilligan, P. H. 1991. Microbiology of airway disease in patients with cystic fibrosis. Clin. Microbiol. Rev. 4:35-51.
5. Govan, J. R., and V. Deretic. 1996. Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol. Rev. 60:539-574.
6. Gu, Y., I. T. Harley, L. B. Henderson, B. J. Aronow, I. Vietor, L. A. Huber, J. B. Harley, J. R. Kilpatrick, C. D. Langefeld, A. H. Williams, A. G. Jegga, J. Chen, M. Wills-Karp, S. H. Arshad, S. L. Ewart, C. L. Thio, L. M. Flick, M. D. Filippi, H. L. Grimes, M. L. Drumm, G. R. Cutting, M. R. Knowles, and C. L. Karp. 2009. Identification of IFRD1 as a modifier gene for cystic fibrosis lung disease. Nature 458:1039-1042.
7. Harrison, F. 2007. Microbial ecology of the cystic fibrosis lung. Microbiology 153:917-923.
8. Heeckeren, A., R. Walenga, M. W. Konstan, T. Bonfield, P. B. Davis, and T. Ferkol. 1997. Excessive inflammatory response of cystic fibrosis mice to bronchopulmonary infection with Pseudomonas aeruginosa. J. Clin. Invest. 100:2810-2815.
9. Henry, D. A., M. E. Campbell, J. J. LiPuma, and D. P. Speert. 1997. Identification of Burkholderia cepacia isolates from patients with cystic fibrosis and use of a simple new selective medium. J. Clin. Microbiol. 35:614-619.
10. Isles, A., I. Maclusky, M. Corey, R. Gold, C. Prober, P. Fleming, and H. Levison. 1984. Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J. Pediatr. 104:206-210.
11. Kashef, N., Q. Behzdian-Jejad, S. Najar-Peerayen, K. Mousavi-Hosseini, M. Moazeni, H. Rezvan, and B. Adibi-Motlagh. 2005. Preliminary investigation on the isolation of alginate produced by mucoid Pseudomonas aeruginosa. Ann. Microbiol. 55:279-282.
12. Kravchenko, V. V., G. F. Kaufmann, J. C. Mathison, D. A. Scott, A. Z. Katz, D. C. Grauer, M. Lehmann, M. M. Meijler, K. D. Janda, and R. J. Ulevitch. 2008. Modulation of gene expression via disruption of NF-kappaB signaling by a bacterial small molecule. Science 321:259-263.
13. Krieg, D. P., R. J. Helmke, V. F. German, and J. A. Mangos. 1988. Resistance of mucoid Pseudomonas aeruginosa to nonopsonic phagocytosis by alveolar macrophages in vitro. Infect. Immun. 56:3173-3179.
14. Lamothe, J., K. K. Huynh, S. Grinstein, and M. A. Valvano. 2007. Intracellular survival of Burkholderia cenocepacia in macrophages is associated with a delay in the maturation of bacteria-containing vacuoles. Cell. Microbiol. 9:40-53.
15. Learn, D. B., E. P. Brestel, and S. Seetharama. 1987. Hypochlorite scavenging by Pseudomonas aeruginosa alginate. Infect. Immun. 55:1813-1818.
16. Leid, J. G., C. J. Willson, M. E. Shirtliff, D. J. Hassett, M. R. Parsek, and A. K. Jeffers. 2005. The exopolysaccharide alginate protects Pseudomonas aeruginosa biofilm bacteria from IFN-gamma-mediated macrophage killing. J. Immunol. 175:7512-7518.
17. McKenney, D., K. E. Brown, and D. G. Allison. 1995. Influence of Pseudomonas aeruginosa exoproducts on virulence factor production in Burkholderia cepacia: evidence of interspecies communication. J. Bacteriol. 177:6989-6992.
18. Meshulam, T., N. Obedeanu, D. Merzbach, and J. D. Sobel. 1984. Phagocytosis of mucoid and nonmucoid strains of Pseudomonas aeruginosa. Clin. Immunol. Immunopathol. 32:151-165.
19. Morissette, C., C. Francoeur, C. Darmond-Zwaig, and F. Gervais. 1996. Lung phagocyte bactericidal function in strains of mice resistant and susceptible to Pseudomonas aeruginosa. Infect. Immun. 64:4984-4992.
20. Morissette, C., E. Skamene, and F. Gervais. 1995. Endobronchial inflammation following Pseudomonas aeruginosa infection in resistant and susceptible strains of mice. Infect. Immun. 63:1718-1724.
21. Moser, C., S. Kjaergaard, T. Pressler, A. Kharazmi, C. Koch, and N. Hoiby. 2000. The immune response to chronic Pseudomonas aeruginosa lung infection in cystic fibrosis patients is predominantly of the Th2 type. APMIS 108:329-335.
22. Moser, C., M. Van Gennip, T. Bjarnsholt, P. O. Jensen, B. Lee, H. P. Hougen, H. Calum, O. Ciofu, M. Givskov, S. Molin, and N. Hoiby. 2009. Novel experimental Pseudomonas aeruginosa lung infection model mimicking long-term host-pathogen interactions in cystic fibrosis. APMIS 117:95-107.
23. Mrsny, R. J., B. A. Lazazzera, A. L. Daugherty, N. L. Schiller, and T. W. Patapoff. 1994. Addition of a bacterial alginate lyase to purulent CF sputum in vitro can result in the disruption of alginate and modification of sputum viscoelasticity. Pulm. Pharmacol. 7:357-366.
24. Newcomb, D. C., U. S. Sajjan, D. R. Nagarkar, Q. Wang, S. Nanua, Y. Zhou, C. L. McHenry, K. T. Hennrick, W. C. Tsai, J. K. Bentley, N. W. Lukacs, S. L. Johnston, and M. B. Hershenson. 2008. Human rhinovirus 1B exposure induces phosphatidylinositol 3-kinase-dependent airway inflammation in mice. Am. J. Respir. Crit. Care Med. 177:1111-1121
25. Ojielo, C. I., K. Cooke, P. Mancuso, T. J. Standiford, K. M. Olkiewicz, S. Clouthier, L. Corrion, M. N. Ballinger, G. B. Toews, R. Paine III, and B. B. Moore. 2003. Defective phagocytosis and clearance of Pseudomonas aeruginosa in the lung following bone marrow transplantation. J. Immunol. 171: 4416-4424.
26. Oliver, A. M., and D. M. Weir. 1985. The effect of Pseudomonas alginate on rat alveolar macrophage phagocytosis and bacterial opsonization. Clin. Exp. Immunol. 59:190-196.
27. Painter, R. G., R. W. Bonvillain, V. G. Valentine, G. A. Lombard, S. G. LaPlace, W. M. Nauseef, and G. Wang. 2008. The role of chloride anion and CFTR in killing of Pseudomonas aeruginosa by normal and CF neutrophils. J. Leukoc. Biol. 83:1345-1353.
28. Painter, R. G., V. G. Valentine, N. A. Lanson, Jr., K. Leidal, Q. Zhang, G. Lombard, C. Thompson, A. Viswanathan, W. M. Nauseef, G. Wang, and G. Wang. 2006. CFTR expression in human neutrophils and the phagolysosomal chlorination defect in cystic fibrosis. Biochemistry 45:10260-10269.
29. Pedersen, S. S., F. Espersen, N. Hoiby, and G. H. Shand. 1989. Purification, characterization, and immunological cross-reactivity of alginates produced by mucoid Pseudomonas aeruginosa from patients with cystic fibrosis. J. Clin. Microbiol. 27:691-699.
30. Pedersen, S. S., A. Kharazmi, F. Espersen, and N. Hoiby. 1990. Pseudomonas aeruginosa alginate in cystic fibrosis sputum and the inflammatory response. Infect. Immun. 58:3363-3368.
31. Riedel, K., M. Hentzer, O. Geisenberger, B. Huber, A. Steidle, H. Wu, N. Hoiby, M. Givskov, S. Molin, and L. Eberl. 2001. N-acylhomoserine- lactone-mediated communication between Pseudomonas aeruginosa and Burkholderia cepacia in mixed biofilms. Microbiology 147:3249- 3262.
32. Saiman, L., G. Cacalano, and A. Prince. 1990. Pseudomonas cepacia adherence to respiratory epithelial cells is enhanced by Pseudomonas aeruginosa. Infect. Immun. 58:2578-2584.
33. Sajjan, U., M. Corey, A. Humar, E. Tullis, E. Cutz, C. Ackerley, and J. Forstner. 2001. Immunolocalisation of Burkholderia cepacia in the lungs of cystic fibrosis patients. J. Med. Microbiol. 50:535-546.
34. Sajjan, U., S. Keshavjee, and J. Forstner. 2004. Responses of well-differentiated airway epithelial cell cultures from healthy donors and patients with cystic fibrosis to Burkholderia cenocepacia infection. Infect. Immun. 72:4188-4199.
35. Sajjan, U., G. Thanassoulis, V. Cherapanov, A. Lu, C. Sjolin, B. Steer, Y. J. Wu, O. D. Rotstein, G. Kent, C. McKerlie, J. Forstner, and G. P. Downey. 2001. Enhanced susceptibility to pulmonary infection with Burkholderia cepacia in Cftr(-/-) mice. Infect. Immun. 69:5138-5150.
36. Sajjan, U., Y. Wu, G. Kent, and J. Forstner. 2000. Preferential adherence of cable-piliated Burkholderia cepacia to respiratory epithelia of CF knockout mice and human cystic fibrosis lung explants. J. Med. Microbiol. 49:875-885.
37. Sajjan, U. S., M. Corey, M. A. Karmali, and J. F. Forstner. 1992. Binding of Pseudomonas cepacia to normal human intestinal mucin and respiratory mucin from patients with cystic fibrosis. J. Clin. Invest. 89:648-656.
38. Sajjan, U. S., Y. Jia, D. C. Newcomb, J. K. Bentley, N. W. Lukacs, J. J. LiPuma, and M. B. Hershenson. 2006. H. influenzae potentiates airway epithelial cell responses to rhinovirus by increasing ICAM-1 and TLR3 expression. FASEB J. 20:2121-2123.
39. Sajjan, U. S., J. H. Yang, M. B. Hershenson, and J. J. LiPuma. 2006. Intracellular trafficking and replication of Burkholderia cenocepacia in human cystic fibrosis airway epithelial cells. Cell. Microbiol. 8:1456-1466.
40. Speert, D. P. 2002. Advances in Burkholderia cepacia complex. Paediatr Respir. Rev. 3:230-235.
41. Tsai, W. C., M. B. Hershenson, Y. Zhou, and U. Sajjan. 2009. Azithromycin increases survival and reduces lung inflammation in cystic fibrosis mice. Inflamm. Res. 58:491-501.
42. Tsai, W. C., R. M. Strieter, J. M. Wilkowski, K. A. Bucknell, M. D. Burdick, S. A. Lira, and T. J. Standiford. 1998. Lung-specific transgenic expression of KC enhances resistance to Klebsiella pneumoniae in mice. J. Immunol. 161: 2435-2440.
43. Wahab, A. A., I. A. Janahi, M. M. Marafia, and S. El-Shafie. 2004. Microbiological identification in cystic fibrosis patients with CFTR I1234V mutation. J. Trop. Pediatr. 50:229-233.
44. Wilson, K. R., J. M. Napper, J. Denvir, V. E. Sollars, and H. D. Yu. 2007. Defect in early lung defence against Pseudomonas aeruginosa in DBA/2 mice is associated with acute inflammatory lung injury and reduced bactericidal activity in naive macrophages. Microbiology 153:968-979.
45. Zeitlin, P. L., L. Lu, J. Rhim, G. Cutting, G. Stetten, K. A. Kieffer, R. Craig, and W. B. Guggino. 1991. A cystic fibrosis bronchial epithelial cell line: immortalization by adeno-12-SV40 infection. Am. J. Respir. Cell Mol. Biol. 4:313-319.